Can AAV continue to deliver the promise of gene therapy?

Ratish Krishnan, Elie Hanania

14 September 2023

Podcast

Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?

Valeria Annibaldi, Andrea Toell

01 August 2023

Podcast

Interview: Navigating the complexities of biodistribution, transgene expression & vector shedding in gene therapy development

Paul Byrne

10 June 2023

Podcast

Maximizing efficiency & flexibility in viral vector manufacturing scale-up

D Kole, J Petrone, M Bisschops et al

07 March 2023

Podcast

Improvement of viral vector purification using Mustang®️ Q membrane chromatography

09 January 2023

Podcast

Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing

Ratish Krishnan, Akshat Gupta

10 November 2022

Podcast

Insights into the editing of the human genome: where can novel non-viral polymeric delivery agents take us

Tom Foti, Kris Saha

30 August 2022

Podcast

Achieving better AAV vector productivity and product quality

Diane Golebiowski, Marissa Stanvick

22 July 2022

Podcast

The quest for the Holy Grail in AAV chromatography: empty–full separation

Ratish Krishnan, Oliver Rammo

19 May 2022

Podcast

Residual DNA testing in viral vector manufacture: exploring the challenges and solutions

Ilaria Scarfone, Mike Brewer

22 February 2022

Podcast

Advancing real-time monitoring of AAV vector processes

Rachel Legmann, Joe Ferraiolo

11 October 2021

Podcast

Improving AAV vector manufacture: a question of scale

Silke Wissing, Juliana Coronel

29 April 2021

Podcast

Get in line: developing in-process analytical tools for gene therapy applications

René Gantier, Ramsey Shanbaky, Jay West

10 February 2021

Podcast

Empty/full separation: gene therapy’s hidden challenge

22 January 2021

Podcast

An innovative collaborative approach towards the development of gene therapies for rare and ultra-rare genetic disorders of the CNS

Leszek Lisowski, PhD, MBA, Wendy Gold

22 December 2020

Podcast

Viral vector manufacturing and transfection efficiency in the iCELLis® Bioreactor System

Rachel Leggmann, François Collard, Alengo Nyamay’Antu

17 December 2020

Podcast

Maximizing speed to market: flexibility benefits of single-use technology for gene therapy manufacture – Podcast

Hélène Pora

04 May 2020

Podcast

Evolution of culture systems for viral vector production: advantages, challenges and cost considerations – Podcast

Emmanuelle Cameau, Joseph Capone

10 March 2020

Podcast

Identifying and mitigating risks in the viral vector supply chain - Podcast

Claire Wartel-Weill, Ulises Villavicencio

01 November 2019

Podcast

Determining the optimal culture system for your scale up strategy

Marco Koppe, Clive Glover

28 May 2019

Podcast

Room for improvement: tackling suboptimal downstream process unit operations for viral vectors

Dr Damian Marshall, Prof. Daniel Smith, Clive Glover

18 March 2019

Podcast